ホームページへ
4.6/5
TrustPilot

ラマト・ガンで最高の血管炎医師 - トップ1名の医師

イスラエルのトップ血管炎医師と価格を比較。こちらで最適なマッチングを見つけてください

イスラエル
ラマト・ガン

イスラエルの3名のトップ専門家から見積もりを取得

ご要望と予算に基づいて最適な医師を厳選いたします

医学的監修者 Fahad Mawlood

医学編集者・データサイエンティスト

トップ医師

1

イスラエル

レビュー

14000+

実際の患者より

個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし

pnina Langevich

  • 新着
  • 40年の経験
  • 所在地： イスラエル, ラマト・ガン
  • クリニック：
    5.0
    シェバ医療センター

  • Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

    She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

    She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.

  • 続きを読む
診察
お問い合わせください

海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。

ヤン・マツィイフスキー

医療コーディネーターチーム責任者

4300+件以上の患者の旅をガイド

Bookimedで3年

Israelの142名の患者が今月当社を通じて医師を見つけました

完璧な医師マッチングを取得する方法

1

2分のクイズ

目標、予算、スケジュールをお聞かせください

2

人間のマッチング + AI

アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します

3

オプション準備完了

価格、パッケージ、日程を比較。コーディネーターとチャット

選択肢に迷っていますか？

専属の Bookimedコーディネーターがお客様のニーズに合わせた完璧な外科医を見つけるお手伝いをします

  • すべての段階で24時間365日サポート
  • 医師とのマッチングサポートとクリニックとの全てのコミュニケーションを処理
  • 旅行、宿泊、送迎を調整します

治療をガイド

医療訓練を受けた専属コーディネーター

Peguy Beaugris
Tetyana Hyrych
Zekra Eldeeb
Victoria Olayinka
Iryna Sydorchuk
Tetiana Ihnatiuk

適切な医師とクリニックの選び方：内部者のヒント

医師やクリニックを選ぶ際は、これらの重要なポイントを覚えておいてください：
資格を確認
ISAPS、JCI、または関連医学会などの機関からの認証を確認してください
成功率を確認
お客様の特定治療に豊富な経験と実績のある医師をお選びください
患者レビューを読む
実際の患者様のBookimedレビューをご覧になり、体験について学んでください
効果的なコミュニケーションの確保
円滑な治療のため言語サポートを提供するクリニックを選んでください。
サービスについて質問
隠れた費用を避けるため、価格に宿泊、現地送迎、アフターケアなどのサービスが含まれているかご確認ください

Bookimed洞察：イスラエルのトップ血管炎専門家（2026）

Bookimedはイスラエルの血管炎治療リクエスト3件を調整し、1名のトップ評価専門家と協力しています。この表の医師は国際的資格、臨床専門知識、患者の結果に基づいて選ばれています。2026年ランキングは実際の患者ケースとパートナークリニックの現行プログラムからの検証済みデータを使用して形成されています
順位医師経験適合する方特色クリニックと所在地診察

FAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

Who are the top specialists for vasculitis treatment in Israel?

Top vasculitis specialists in Israel include Prof. Dan Kaspy and Prof. Ori Elkayam at Sourasky Medical Center. Prof. Merav Lidar and Prof. Pnina Langevitz lead advanced immunology programs at Sheba Medical Center. These experts utilize biological therapies and specialized diagnostics for complex autoimmune cases.

  • Prof. Dan Kaspy: Works at Sourasky Medical Center specializing in complex rheumatology.
  • Prof. Merav Lidar: Heads the Center for Autoimmune Diseases at Sheba Medical Center.
  • Prof. Eldad Ben-Chetrit: Specializes in autoinflammatory diseases at Hadassah Medical Center.
  • Clinical expertise: Israeli specialists often hold leadership roles in the Israeli Association of Rheumatology.

Bookimed Expert Insight: Israeli rheumatology departments show a distinct pattern of specialization across different hospitals. While Sourasky Medical Center serves over 400,000 patients annually and excels in research trials, Sheba Medical Center is the primary hub for rare refractory cases. For patients requiring high-tech biological infusions like rituximab, university-affiliated public hospitals often provide more established clinical protocols than smaller private clinics.

Patient Consensus: Patients note that while treatment quality is exceptional, navigating hospital bureaucracy is challenging without professional logistics support. Many emphasize the importance of choosing major centers like Sheba or Rabin for comprehensive biopsy and steroid protocols.

What advanced treatment options for vasculitis are available in Israeli clinics?

Israeli clinics provide advanced vasculitis treatments including CAR-T cell therapy, biologic protocols, and extracorporeal hemocorrection. Specialists at JCI-accredited centers like Sourasky Medical Center (Ichilov) utilize rituximab, JAK inhibitors, and tocilizumab. These therapies target specific immune pathways to manage systemic inflammation and prevent organ damage effectively.

  • Biologic therapy: Targeted drugs like rituximab and tocilizumab block specific inflammatory proteins.
  • CAR-T therapy: Innovative T-cell engineering at Sheba Medical Center treats resistant ANCA-associated cases.
  • Plasma exchange: Plasmapheresis removes harmful autoantibodies from the blood during acute flares.
  • Precision diagnostics: Multimodal imaging with PET-CT and MRI tracks large-vessel vascular changes.

Bookimed Expert Insight: Israeli rheumatology departments often provide faster access to experimental biologic combinations. Data shows centers like Sourasky Medical Center (Ichilov) integrate research directly into clinical care. Dr. Dan Kaspy leads the Rheumatology Department there with extensive international expertise. This connection to research allows patients to access JAK inhibitors and personalized dosing protocols earlier.

Patient Consensus: Patients appreciate that Israeli hospitals use genetic profiling to tailor biologic treatments. They note that the multidisciplinary teams react quickly to adjust dosages based on real-time monitoring.

Which hospitals in Israel are best for vasculitis care?

Top Israeli hospitals for vasculitis include Sheba Medical Center and Sourasky Medical Center. These facilities utilize multidisciplinary teams and advanced biological treatments. Clinics often hold Joint Commission International (JCI) accreditation. Specialized centers like Hadassah and Rambam provide research-driven care for complex autoimmune conditions.

  • Specialized expertise: Dr. Dan Kaspy at Sourasky focuses on complex rheumatology and immunology.
  • Advanced diagnostics: Facilities use digital imaging and AI to identify specific vasculitis types.
  • Clinical research: University hospitals like Hadassah integrate new discoveries into patient treatment plans.
  • Treatment range: Options include biological therapies and experimental protocols for refractory cases.

Bookimed Expert Insight: While Israel has 26 clinics in our network, Sourasky Medical Center stands out for its high volume. It serves over 1,800,000 patients annually and employs 2,200 doctors. This massive scale allows for extreme specialization. Dr. Dan Kaspy, for example, is a founding member of Israel’s rheumatology programs. For rare conditions like vasculitis, choosing a high-volume academic center ensures access to such foundational expertise.

Patient Consensus: Patients note that research-driven units at centers like Hadassah often provide faster access to biologics. Many suggest using private insurance to bypass long public waitlists for specialist consultations.

How long should international patients plan to stay for advanced vasculitis treatment in Israel?

International patients usually stay 2 to 4 weeks for advanced vasculitis treatment in Israel. This window covers diagnostics, treatment initiation, and acute monitoring. Cases involving renal or pulmonary complications often require 3 to 4 weeks. Oral-only regimens may allow for shorter stays of 7 to 10 days.

  • Diagnostic phase: Comprehensive workups typically require 5 to 10 days in Tel Aviv clinics.
  • Intensive induction: IV immunosuppression protocols generally last 10 to 21 days for initial infusions.
  • Inpatient care: Severe systemic cases often involve 9 to 16 days of specialized hospitalization.
  • Advanced therapies: Cellular treatments like CAR-T therapy may extend total stays to 10 weeks.

Bookimed Expert Insight: Coordination between Israeli specialists and home doctors is the most effective way to reduce stay duration. At Sourasky Medical Center, experts like Dr. Dan Kaspy oversee complex cases that often involve multiple departments. Patients who arrange for remote follow-ups after 10 to 14 days of stabilization can safely transition to maintenance therapy at home. Choosing a facility with built-in telemedicine capabilities ensures ongoing care without requiring monthly return flights to Israel.

Patient Consensus: Patients note it's important to build in a 5-day buffer for unexpected lab repeats or imaging. They emphasize that while the initial stay is intense, transition to maintenance therapy usually happens smoothly after the first month.